Critics have questioned the objectivity of medical journal editors and peer reviewers, asking whether these “watchers” are preventing the best innovations from reaching professional readers.
By John Halamka, M.D., Diercks President, Mayo Clinic Platform and…
Continue Reading
It’s a common refrain in hospitals, health systems and other enterprises: As technology increases in popularity and usefulness, the sprawl that ensues makes management and governance more difficult. In that sense, artificial intelligence tools…
Continue Reading
News
[embedded content]
Google releases Gemini 3 and Google Antigravity, a new agentic AI development platform.
Microsoft announces Agent 365, which helps enterprises deploy, organize, and govern agents that are developed internally or provided by…
Current AI approaches for cardiac diagnosis require condition-specific supervised learning with extensive labeled datasets, leading to fundamental scalability barriers. We developed an ECG-CLIP model, applying contrastive multimodal learning to enable zero-shot cardiac diagnosis from…
Continue Reading
The complexity and variability of high-resolution pathological images present significant challenges in computational pathology. While AI-driven pathology foundation models have advanced the field, they require large-scale datasets, substantial storage, and significant computational resources, as…
Continue Reading
[embedded content]
What You Should Know:
– Arbiter, a new AI-powered care orchestration platform, has launched from stealth with $52M in funding, led by TriEdge Investments and MFO Ventures, to unite payers, providers, and patients and…
Continue Reading
HIMSS Forum: The challenge of advancing secure AI in healthcare | MobiHealthNews
Skip to main content…
Continue Reading
What You Should Know:
– Ember, the AI-native solution for denial prevention secures $4.3M in seed funding round led by Nexus Venture Partners and Y Combinator.
– Its platform uses deep knowledge of payer policies to…
Continue Reading
If you’ve ever watched a clinician dig through an EHR for a single piece of information, you know the look. The pause. The sigh. The slow click-through of screens that feel like they were…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
